STAT

SEPTEMBER 23, 2024

The health data company Particle Health has filed an antitrust lawsuit against Epic Systems, alleging that the electronic health record vendor has used its control of patient data to thwart competition and undermine its business. The suit filed Monday in federal court in the Southern District of New York is a full-throated assault on Epic’s dominance in the market for electronic health records, charging that the privately held company has become a “behemoth” and a “mo

363

363

LifeProNow

SEPTEMBER 23, 2024

Decentralized clinical trials (DCTs) are an innovative approach to conducting clinical research, where some or all trial-related activities occur at locations other than traditional clinical trial sites. These locations can include participants’ homes, local healthcare facilities, or nearby laboratories. Key Features of DCTs: Remote Participation: Participants can engage in the trial from their homes or local clinics, reducing the need for travel.

Diabetes 130

Diabetes 130

STAT

SEPTEMBER 23, 2024

WASHINGTON — The wheels on a big red bus emblazoned with anti-pharmaceutical industry messaging are going ’round and ’round all through the nation’s electoral battlegrounds, from Montana to Arizona to Pennsylvania. But nobody will say who’s paying to fill up the gas tank. A new dark-money group called Americans for Pharma Reform has launched a multi-state bus tour to bring awareness to what they characterize as bad behavior by the pharmaceutical industry.

Drug Pricing 359

Drug Pricing 359

PharmaVoice

SEPTEMBER 23, 2024

A new report examines the patient reach efforts of 20 of the world’s largest pharma companies in low- and middle-income countries.

130

130

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

SEPTEMBER 23, 2024

WASHINGTON — Of the roughly 15 million Americans who tried to quit smoking in 2022, 5 in 6 failed. It’s a jarring statistic — and an indictment of the treatment options for an addiction that kills 480,000 people in the U.S. each year. The smoking-cessation drugs on the market don’t work well for the majority of people, and they come with side effects and reputations that keep some smokers from ever trying them.

Vaccines 359

Vaccines Drug Development 359

BioPharma Dive

SEPTEMBER 23, 2024

The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.

120

120

The Pharmacist

SEPTEMBER 23, 2024

The Company Chemists' Association (CCA) has called on the government and the NHS to commission a national diabetes screening service from within community pharmacies. This should be underpinned by 'seamless IT referral pathways' and patient pathways allowing independent prescribing pharmacists to initiate treatment where needed, the trade body, which represents large multiple pharmacies, said.

Diabetes 112

Diabetes Community Pharmacies 112

STAT

SEPTEMBER 23, 2024

The federal watchdog at the Department of Health and Human Services issued a report on Tuesday calling for more oversight of remote patient monitoring in Medicare. The Office of Inspector General’s report called out the potential for fraud and misuse of tools like at-home blood pressure cuffs, connected scales, and continuous glucose monitors that can feed data directly to a patient’s doctor.

348

348

BioPharma Dive

SEPTEMBER 23, 2024

With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.

120

120

STAT

SEPTEMBER 23, 2024

On Tuesday, the Department of Health and Human Services published new policies  on research misconduct , which apply to research institutions receiving funding through the U.S. Public Health Service. The policies set standards that institutions must follow when investigating and potentially sanctioning researchers alleged to have engaged in research misconduct.

334

334

Speaker: Joe Sharpe and James Carlson

Running a small business is no small feat. Payroll management, in particular, can be one of the most time-consuming and complex parts of that equation. Yet, businesses that crack the code on streamlining these processes often discover not just savings, but new avenues for growth. Our expert speakers will share actionable insights and real-world examples of how businesses have reduced overhead and improved payroll efficiency.

Drug Patent Watch

SEPTEMBER 23, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the expiration of patents on branded drugs and the increasing demand for affordable healthcare solutions. However, the industry faces several challenges, including commoditization, regulatory hurdles, and intense competition.

103

103

STAT

SEPTEMBER 23, 2024

Biogen and UCB said Tuesday that an experimental drug reduced disease activity and symptoms of systemic lupus, achieving the primary goal of a placebo-controlled Phase 3 study.  Detailed study results were not included in the press release issued by the companies, so how much participants benefited from the drug, called dapirolizumab pegol, won’t be known until data are presented at a medical meeting.

332

332

Express Pharma

SEPTEMBER 23, 2024

The H5N1 virus, known for its 50 per cent human case fatality rate, has persisted globally for over two decades, causing thousands of infections. The recent outbreaks, including those affecting US dairy cows, have accelerated the development of next-generation vaccines, with mRNA vaccines stepping into the spotlight, aiming to replicate the success achieved during the COVID-19 pandemic, says GlobalData.

Vaccines 103

Vaccines 103

STAT

SEPTEMBER 23, 2024

The GLP-1 drug Wegovy tops the list of medications expected to be included in the next round of Medicare price negotiations, according to a paper in the Journal of Managed Care & Specialty Pharmacy.  Last month, Medicare officials unveiled prices for the first 10 drugs chosen for negotiation. Now, all eyes are on which Part D drugs will be chosen for the next round of 15 drugs.

Specialty Pharmacies 324

Specialty Pharmacies Diabetes Drug Pricing 324

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

SEPTEMBER 23, 2024

AstraZeneca Pharma has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India for the below mentioned additional indication, subject to the receipt of related statutory approvals, if any.

Chemotherapy 99

Chemotherapy 99

STAT

SEPTEMBER 23, 2024

Good morning! Health care challenges like anti-microbial resistance have long created narrative tension for shows like Grey’s Anatomy. But what about an entire musical about it? Ask and ye shall receive. The wheels on the anti-pharma bus … echo GOP talking points A new, dark money group called Americans for Pharma Reform is aiming to bring awareness to what they call bad behavior by the pharmaceutical industry.

275

275

The Pharmacist

SEPTEMBER 23, 2024

Almost half of pharmacies in England have seen a reduction in Pharmacy First electronic referrals from GP practices since many GPs began 'working to rule' last month, a poll by Community Pharmacy England (CPE) has suggested. A survey of 4,589 pharmacy premises in England in September has revealed the impact of collective action taken by […] The post Reduced Pharmacy First referrals since GP action, poll suggests appeared first on The Pharmacist.

Community Pharmacies 94

Community Pharmacies 94

STAT

SEPTEMBER 23, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because — you guessed it — that oh-so familiar routine of online meetings, annoying commutes, and deadlines has predictably returned. But what can you do? The world, such as it is, somehow continues to spin no matter how hard we try to slow it down.

274

274

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

SEPTEMBER 23, 2024

India Ratings and Research (Ind-Ra) has projected weak growth in prices and volumes for active pharmaceutical ingredients (APIs) in India for FY25. This is attributed to competition from Chinese imports and exports. Despite this, lower raw material costs have cushioned the effects of price declines. This, combined with forward integration into the formulations business, has resulted in expanded EBITDA margins for pharmaceutical companies.

Pharmaceutical Companies 90

Pharmaceutical Companies Pharmaceutical Companies 90

STAT

SEPTEMBER 23, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning! Today, we discuss a bus with anti-pharma messaging that’s traversing the country, we see the FTC file a suit against the three biggest pharmaceutical benefit managers, and more.

Drug Pricing 272

Drug Pricing Drug Development 272

pharmaphorum

SEPTEMBER 23, 2024

RHYTHM AI has FDA approval for a new version of its algorithm for mapping areas of the heart that are affected by atrial fibrillation

105

105

STAT

SEPTEMBER 23, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. FTC v. the Big 3 Kevin Dietsch/Getty Images The animosity between the Federal Trade Commission and pharmacy benefit managers has reached a boiling point. The FTC sued the nation’s three biggest PBMs last week, accusing them and their secretive group purchasing organizations of creating a “perver

Drug Development 263

Drug Development 263

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

SEPTEMBER 23, 2024

Zevra Therapeutics' Miplyffa is first drug approved by the FDA for ultra-rare disease Niemann-Pick type C.

115

115

Pharmaceutical Technology

SEPTEMBER 23, 2024

Download our free, extensive list of the leading Active Pharmaceutical Ingredients and Intermediates companies and suppliers today.

98

98

pharmaphorum

SEPTEMBER 23, 2024

Johnson & Johnson's long-running effort to put litigation claiming its talc products caused cancer has continued with a third attempt to place a subsidiary company into bankruptcy. Red River Talc LLC was set up specifically to resolve the thousands of claims related to ovarian cancer arising from cosmetic talc litigation, separated from the group's core business and armed with billions of dollars in settlement money to provide compensation to alleged victims.

89

89

Pharmaceutical Technology

SEPTEMBER 23, 2024

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration.

Vaccines 96

Vaccines 96

Express Pharma

SEPTEMBER 23, 2024

Researchers have developed catalytic droplets that can lead to a 10-fold increase in speed and efficient catalytic reactions and this is valid below a critical substrate concentration. Such efficient chemical reactions can accelerate drug development, leading to quicker access to innovative medications and potentially lower healthcare costs. Traditionally, chemists have relied on physical and chemical barriers to confine molecules during catalytic reactions.

Drug Development 76

Drug Development 76

Pharmaceutical Technology

SEPTEMBER 23, 2024

View the top artificial intelligence (AI) companies in the pharmaceutical industry and download your free guide to AI in pharma here.

94

94

pharmaphorum

SEPTEMBER 23, 2024

Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson and Genmab's blockbuster Darzalex, but now has a chance to steal some of the spotlight. The FDA has approved Sarclisa (isatuximab) as a first-line therapy for blood cancer multiple myeloma as a combination regimen alongside bortezomib, lenalidomide, and dexamethasone (VRd), for people who are not eligible for an autologous stem cell transplant (ASCT).

78

78

BioPharma Dive

SEPTEMBER 23, 2024

Regulatory and strategic challenges can delay the delivery of life-changing cell and gene therapies.

98

98

EMCrit Project

SEPTEMBER 23, 2024

All things Vascular Access with the Vascular Guy EMCrit Project by Scott Weingart, MD FCCM.

102

102

Express Pharma

SEPTEMBER 23, 2024

Dr R. N. Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA) for the term 2024-2026. The IPA is the oldest and largest association of pharmaceutical professionals in India. Dr Gupta’s term will run from October 1, 2024 to 30th September 2026. With nearly five decades of experience in the pharmaceutical industry, academia, and research, Dr Gupta currently serves as an Adjunct Professor at NIPER, Kolkata.

Community Pharmacies 68

Community Pharmacies Hospitals 68